FDA Adverse Event Injury Summary report: N

ENDEAVOR SPRINT RX CORONARY STENT SYSTEM

MDR report key: 2051111 · Received April 5, 2011

Report

Report Number
9612164-2011-00162
Event Type
Injury
Date Received
April 5, 2011
Date of Event
June 7, 2009
Report Date
March 10, 2011
Manufacturer
MEDTRONIC IRELAND
Product Code
NIQ
PMA / PMN Number
P060033
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NJ, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). RESULTS: (MI). CONCLUSION: NO CONCLUSION CAN BE DRAWN (BASED ON THE INFORMATION PROVIDED NO ROOT CAUSE CAN BE DETERMINED).

Description of Event or Problem · 1

PATIENT UNDERWENT INDEX PROCEDURE WITH PRE-TREATMENT BALLOON ANGIOPLASTY AND DELIVERY OF AN ENDEAVOR RESOLUTE RX DRUG ELUTING STENT IN THE MID RCA. REPEAT ANGIOGRAPHY 2 WEEKS LATER FOR A STAGED PROCEDURE IN THE ABSENCE OF RECURRENT CLINICAL SYMPTOMS OR A FUNCTIONAL ISCHEMIA STUDY REVEALED A SITE REPORTED 0% RESTENOSIS OF THE TARGET LESION. THE ANGIOGRAPHIC CORE LAB REPORTED A 22% IN-LESION RESTENOSIS OF THE TARGET LESION. THE CATHETERIZATION REPORT NOTED AN 80% STENOSIS OF THE DISTAL CX. THE PATIENT UNDERWENT REPEAT REVASCULARIZATION WITH PLACEMENT OF AN ENDEAVOR SPRINT RX DRUG ELUTING STENT IN THE DISTAL CX. THE SITE REPORTED, THE PATIENT WAS REHOSPITALIZED APPROXIMATELY 4 MONTHS POST INDEX PROCEDURE FOR AN MI. REPEAT ANGIOGRAPHY FOR RECURRENT CLINICAL SYMPTOMS AND A POSITIVE FUNCTIONAL ISCHEMIA STUDY REVEALED A 90% STENOSIS OF THE DISTAL RCA AS NOTED IN THE CATHETERIZATION REPORT. THE ANGIOGRAPHIC CORE LAB REPORTED A 27% IN-LESION RESTENOSIS OF THE MID RCA TARGET LESION. THE PATIENT UNDERWENT REPEAT REVASCULARIZATION WITH PLACEMENT OF A NON-MEDTRONIC STENT IN THE DISTAL RCA.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDEAVOR SPRINT RX CORONARY STENT SYSTEM NIQ MEDTRONIC IRELAND NA UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 56 YR Hospitalization CLOPIDOGREL| PRIOR TO EVENT| ASA